Organization Overview
Historical Acquisition Tree
Alternative names
covid-19 vaccine, mrna (Comirnaty) (2021 NDA)
Key: Biontech (4) Acquired (6)
Key: Biontech (27) Acquired (18)
cemiplimab (libtayo) (5 trials)
cisplatin (platinol) (2 trials)
Filgrastim (neupogen) (2 trials)
fluorouracil (efudex) (4 trials)
gamma-glutamyl-s-(benzyl)-cysteinyl-r(-)-phenylglycine diethyl ester (8 trials)
Key: Biontech (18) Acquired (12)
Breast Neoplasms (Phase 1)
Carcinoma (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 2)
Endometrial Neoplasms (Phase 2)
Glioblastoma (Phase 1)
Head and Neck Neoplasms (Phase 2)
Infections (Phase 2)
Kidney Neoplasms (Phase 1)
Melanoma (Phase 2)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 1)
Papilloma (Phase 2)
Penile Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Respiratory Tract Infections (Phase 2)
RNA Virus Infections (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Virus Diseases (Phase 2)